Clinical Trial Update: Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of eribulin followed by doxorubicin and cyclophosphamide for HER2-negative locally advanced breast cancer was terminated, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Halaven (eribulin)

Snippet

Sponsor: Emory University | Conditions: Breast Neoplasms, Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-10-03